Lentinan-Based Oral Nanoparticle Loaded Budesonide With Macrophage-Targeting Ability for Treatment of Ulcerative Colitis

Ulcerative colitis (UC) is a global, chronic, and refractory disease. Corticosteroids are first-line drugs for the treatment of UC but also cause adverse side effects. Budesonide (BUD), a corticosteroid with relatively low side effects, has been approved by the Food and Drug Administration for use a...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Meisi, Dong, Lingling, Chen, Qiyan, Xu, Haiting, Han, Xiaoqin, Luo, Ruifeng, Pu, Xiulan, Qi, Shanshan, Nie, Wenbiao, Ma, Meilin, Wang, Yitao, Gao, Fei, Zhang, Jinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Bioengineering and Biotechnology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429481/
https://www.ncbi.nlm.nih.gov/pubmed/34513811
http://dx.doi.org/10.3389/fbioe.2021.702173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429481/
https://www.ncbi.nlm.nih.gov/pubmed/34513811
http://dx.doi.org/10.3389/fbioe.2021.702173

Ejemplares similares